Item Type | Name |
Academic Article
|
RNA oxidation in Alzheimer disease and related neurodegenerative disorders.
|
Academic Article
|
Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation.
|
Academic Article
|
Mitochondria: a therapeutic target in neurodegeneration.
|
Academic Article
|
Amyloid-beta-derived diffusible ligands cause impaired axonal transport of mitochondria in neurons.
|
Academic Article
|
Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies.
|
Academic Article
|
DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson's disease.
|
Academic Article
|
Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease.
|
Academic Article
|
Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease.
|
Academic Article
|
Cholesterol homeostasis markers are localized to mouse hippocampal pyramidal and granule layers.
|
Academic Article
|
Widespread distribution of reticulon-3 in various neurodegenerative diseases.
|
Academic Article
|
Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease.
|
Academic Article
|
Cellular prion protein is essential for oligomeric amyloid-?-induced neuronal cell death.
|
Academic Article
|
Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover.
|
Academic Article
|
Do ?-defensins and other antimicrobial peptides play a role in neuroimmune function and neurodegeneration?
|
Academic Article
|
The impairment of insulin signaling in Alzheimer's disease.
|
Academic Article
|
Intrahippocampal amyloid-? (1-40) injections injure medial septal neurons in rats.
|
Academic Article
|
LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1.
|
Academic Article
|
Mark A. Smith: neurocytochemistry innovator.
|
Academic Article
|
The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons.
|
Academic Article
|
Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.
|
Academic Article
|
Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance.
|
Academic Article
|
Curcumin/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP/PS1 mouse model.
|
Academic Article
|
Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glass.
|
Academic Article
|
From Neurodegeneration to Brain Health: An Integrated Approach.
|
Academic Article
|
Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets.
|
Academic Article
|
Identification of Inhibitors of CD36-Amyloid Beta Binding as Potential Agents for Alzheimer's Disease.
|
Academic Article
|
Inhibition of mitochondrial fragmentation protects against Alzheimer's disease in rodent model.
|
Academic Article
|
Pathomechanisms of TDP-43 in neurodegeneration.
|
Academic Article
|
The sterol regulatory element-binding protein 2 is dysregulated by tau alterations in Alzheimer disease.
|
Academic Article
|
TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer's Disease.
|
Academic Article
|
Consequences of RNA oxidation on protein synthesis rate and fidelity: implications for the pathophysiology of neuropsychiatric disorders.
|
Academic Article
|
Mfn2 ablation causes an oxidative stress response and eventual neuronal death in the hippocampus and cortex.
|
Academic Article
|
TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration.
|
Academic Article
|
TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease.
|
Academic Article
|
Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.
|
Academic Article
|
Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans.
|
Academic Article
|
The neuroprotective activities of melatonin against the Alzheimer beta-protein are not mediated by melatonin membrane receptors.
|
Academic Article
|
Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins.
|
Academic Article
|
The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease.
|
Academic Article
|
Role of high mobility group protein-1 (HMG1) in amyloid-beta homeostasis.
|
Academic Article
|
4-hydroxynonenal contributes to NGF withdrawal-induced neuronal apoptosis.
|
Academic Article
|
Distribution, levels, and activation of MEK1 in Alzheimer's disease.
|
Academic Article
|
Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
|
Academic Article
|
A metabolic basis for Alzheimer disease.
|
Academic Article
|
Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways.
|
Academic Article
|
Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients.
|
Academic Article
|
Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease.
|
Academic Article
|
Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease.
|
Academic Article
|
Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease.
|
Academic Article
|
Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins.
|
Academic Article
|
Oxidative stress increases expression and activity of BACE in NT2 neurons.
|
Academic Article
|
Is Alzheimer's disease a mitochondrial disorder?
|
Academic Article
|
Role of mitochondrial dysfunction in Alzheimer's disease.
|
Academic Article
|
Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology.
|
Academic Article
|
Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells.
|
Academic Article
|
Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation.
|
Academic Article
|
Possible involvement of Wiskott-Aldrich syndrome protein family in aberrant neuronal sprouting in Alzheimer's disease.
|
Academic Article
|
Oxidative damage in the olfactory system in Alzheimer's disease.
|
Academic Article
|
Will preventing protein aggregates live up to its promise as prophylaxis against neurodegenerative diseases?
|
Academic Article
|
Tipping the apoptotic balance in Alzheimer's disease: the abortosis concept.
|
Academic Article
|
Amyloid-beta-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression.
|
Academic Article
|
Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer's disease.
|
Academic Article
|
Perspectives on the amyloid-beta cascade hypothesis.
|
Academic Article
|
Neuroprotective properties of Bcl-w in Alzheimer disease.
|
Academic Article
|
Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease.
|
Academic Article
|
Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease.
|
Academic Article
|
Mitogen- and stress-activated protein kinase 1: convergence of the ERK and p38 pathways in Alzheimer's disease.
|
Academic Article
|
The cell cycle in Alzheimer disease: a unique target for neuropharmacology.
|
Academic Article
|
P38 activation mediates amyloid-beta cytotoxicity.
|
Academic Article
|
Clusterin up-regulation following sub-lethal oxidative stress and lipid peroxidation in human neuroblastoma cells.
|
Academic Article
|
Neuropathology in Alzheimer's disease: awaking from a hundred-year-old dream.
|
Academic Article
|
Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease.
|
Academic Article
|
Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses.
|
Academic Article
|
Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease.
|
Academic Article
|
c-Jun phosphorylation in Alzheimer disease.
|
Academic Article
|
Staying connected: synapses in Alzheimer disease.
|
Academic Article
|
Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron.
|
Academic Article
|
Effect of quinones on microtubule polymerization: a link between oxidative stress and cytoskeletal alterations in Alzheimer's disease.
|
Academic Article
|
Oxidative stress and neurodegeneration.
|
Academic Article
|
4-Oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenal.
|
Academic Article
|
Metal ions and oxidative protein modification in neurological disease.
|
Academic Article
|
The (un)balance between metabolic and oxidative abnormalities and cellular compensatory responses in Alzheimer disease.
|
Academic Article
|
Alpha-synuclein facilitates the toxicity of oxidized catechol metabolites: implications for selective neurodegeneration in Parkinson's disease.
|
Academic Article
|
Compensatory responses induced by oxidative stress in Alzheimer disease.
|
Academic Article
|
Amyloid-beta, BACE, and oxidative stress in Alzheimer's disease, a commentary on "The different aggregation state of beta-amyloid 1-42 mediates different effects on oxidative stress, neurodegeneration and BACE-1 expression".
|
Academic Article
|
Involvement of oxidative stress in Alzheimer disease.
|
Academic Article
|
Apoptosis in Alzheimer disease: a mathematical improbability.
|
Academic Article
|
Aberrant localization of importin alpha1 in hippocampal neurons in Alzheimer disease.
|
Academic Article
|
Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain.
|
Academic Article
|
Indices of metabolic dysfunction and oxidative stress.
|
Academic Article
|
Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease.
|
Academic Article
|
Oxidative stress and neurotoxicity.
|
Academic Article
|
Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer's disease.
|
Academic Article
|
Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease.
|
Academic Article
|
The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse.
|
Academic Article
|
The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.
|
Academic Article
|
Molecular pathogenesis of Alzheimer's disease: reductionist versus expansionist approaches.
|
Academic Article
|
Nanoparticle-chelator conjugates as inhibitors of amyloid-beta aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease.
|
Academic Article
|
Tau--an inhibitor of deacetylase HDAC6 function.
|
Academic Article
|
Impaired balance of mitochondrial fission and fusion in Alzheimer's disease.
|
Academic Article
|
BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease.
|
Academic Article
|
Signal transduction cascades associated with oxidative stress in Alzheimer's disease.
|
Academic Article
|
Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats.
|
Academic Article
|
The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival.
|
Concept
|
Communication
|
Concept
|
Motor Neurons
|
Concept
|
Multiple Sclerosis
|
Concept
|
Neurons
|
Concept
|
Neurons, Afferent
|
Concept
|
Microglia
|
Academic Article
|
Ultrastructural analysis of a murine model of congenital hydrocephalus produced by overexpression of transforming growth factor-beta1 in the central nervous system.
|
Academic Article
|
Tryptamine induces axonopathy and mitochondriopathy mimicking neurodegenerative diseases via tryptophanyl-tRNA deficiency.
|
Academic Article
|
Nucleic acid oxidative damage in Alzheimer's disease-explained by the hepcidin-ferroportin neuronal iron overload hypothesis?
|
Academic Article
|
An Inducible Alpha-Synuclein Expressing Neuronal Cell Line Model for Parkinson's Disease1.
|
Academic Article
|
Towards an Integrative Understanding of tRNA Aminoacylation-Diet-Host-Gut Microbiome Interactions in Neurodegeneration.
|
Academic Article
|
Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein.
|
Academic Article
|
Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles.
|
Academic Article
|
Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.
|
Academic Article
|
Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis.
|
Academic Article
|
Influence of neuronal location on antigenic properties of neurofibrillary tangles.
|
Academic Article
|
Microglia are associated with the extracellular neurofibrillary tangles of Alzheimer disease.
|
Academic Article
|
Neurochemistry of dementia: establishing the links.
|
Academic Article
|
Hirano body filaments contain actin and actin-associated proteins.
|
Academic Article
|
Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains.
|
Academic Article
|
Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy.
|
Academic Article
|
Hirano bodies contain tau protein.
|
Academic Article
|
Dystrophic neurites define diffuse as well as core-containing senile plaques in Alzheimer's disease.
|
Academic Article
|
Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease.
|
Academic Article
|
The amyloid precursor protein in ischemic brain injury and chronic hypoperfusion.
|
Academic Article
|
Evidence for oxidative stress in Pick disease and corticobasal degeneration.
|
Academic Article
|
Widespread peroxynitrite-mediated damage in Alzheimer's disease.
|
Academic Article
|
Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis.
|
Academic Article
|
Radical AGEing in Alzheimer's disease.
|
Academic Article
|
Chondroitin sulfate proteoglycans are a common component of neuronal inclusions and astrocytic reaction in neurodegenerative diseases.
|
Academic Article
|
Alzheimer disease: an imbalance of proteolytic regulation?
|
Academic Article
|
Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system.
|
Academic Article
|
Accumulation of the beta amyloid precursor protein at sites of ischemic injury in rat brain.
|
Academic Article
|
Oxidative posttranslational modifications in Alzheimer disease. A possible pathogenic role in the formation of senile plaques and neurofibrillary tangles.
|
Academic Article
|
Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.
|
Academic Article
|
4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.
|
Academic Article
|
Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine.
|
Academic Article
|
Striation is the characteristic neuritic abnormality in Alzheimer disease.
|
Academic Article
|
Dimethylargininase, a nitric oxide regulatory protein, in Alzheimer disease.
|
Academic Article
|
Apoptosis and Alzheimer's disease.
|
Academic Article
|
The mosaic of brain glial hyperactivity during normal ageing and its attenuation by food restriction.
|
Academic Article
|
CI-ATPase and Na+/K(+)-ATPase activities in Alzheimer's disease brains.
|
Academic Article
|
Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons.
|
Academic Article
|
In situ methods for detection and localization of markers of oxidative stress: application in neurodegenerative disorders.
|
Academic Article
|
In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification.
|
Academic Article
|
Will antioxidants fulfill their expectations for the treatment of Alzheimer disease?
|
Academic Article
|
Redox-active iron mediates amyloid-beta toxicity.
|
Academic Article
|
Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.
|
Academic Article
|
Protein disulfide isomerase in Alzheimer disease.
|
Academic Article
|
Biochemistry of neurodegeneration.
|
Academic Article
|
Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease.
|
Academic Article
|
A suicide note from Alzheimer disease neurons?
|
Academic Article
|
RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease.
|
Academic Article
|
Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation.
|
Academic Article
|
Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome.
|
Academic Article
|
Overexpression of heme oxygenase in neuronal cells, the possible interaction with Tau.
|
Academic Article
|
Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc.
|
Academic Article
|
Oxidative damage in Alzheimer's disease: the metabolic dimension.
|
Academic Article
|
Activation of NADPH oxidase in Alzheimer's disease brains.
|
Academic Article
|
Oxidative stress in Alzheimer's disease.
|
Academic Article
|
Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease.
|
Academic Article
|
Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome.
|
Academic Article
|
Do neurons have a choice in death?
|
Academic Article
|
Mitochondrial abnormalities in Alzheimer's disease.
|
Academic Article
|
Melatonin acts as antioxidant and pro-oxidant in an organotypic slice culture model of Alzheimer's disease.
|
Academic Article
|
Abortive apoptosis in Alzheimer's disease.
|
Academic Article
|
Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.
|
Academic Article
|
Oxidative damage is the earliest event in Alzheimer disease.
|
Academic Article
|
Possible protective mechanisms of heme oxygenase-1 in the brain.
|
Academic Article
|
Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways.
|
Academic Article
|
Retinoic acid isomers protect hippocampal neurons from amyloid-beta induced neurodegeneration.
|
Academic Article
|
Synaptic dysfunction and oxidative stress in Alzheimer's disease: emerging mechanisms.
|
Academic Article
|
Brain and brawn: parallels in oxidative strength.
|
Academic Article
|
Causes of oxidative stress in Alzheimer disease.
|
Academic Article
|
Neuronal binucleation in Alzheimer disease hippocampus.
|
Academic Article
|
Oxidative RNA damage and neurodegeneration.
|
Academic Article
|
Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases.
|
Academic Article
|
Abnormal mitochondrial dynamics--a novel therapeutic target for Alzheimer's disease?
|
Academic Article
|
A novel perspective on tau in Alzheimer's disease.
|
Academic Article
|
Transplantation of Human Chorion-Derived Cholinergic Progenitor Cells: a Novel Treatment for Neurological Disorders.
|
Academic Article
|
Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice.
|
Grant
|
RCMI Center for Interdiscplinary Health Research CIHR
|
Grant
|
RCMI Center for Interdiscplinary Health Research CIHR
|
Grant
|
AMYLOID PRECURSOR IN ALZHEIMER DISEASE
|
Grant
|
NEUROFIBRILLARY PATHOLOGY IN ALZHEIMER DISEASE
|
Academic Article
|
Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration.
|
Academic Article
|
A Multilevel View of the Development of Alzheimer's Disease.
|
Academic Article
|
A brief guide to the science and art of writing manuscripts in biomedicine.
|
Academic Article
|
Gut-microbiota-microglia-brain interactions in Alzheimer's disease: knowledge-based, multi-dimensional characterization.
|
Academic Article
|
Mitochondrial Fusion Suppresses Tau Pathology-Induced Neurodegeneration and Cognitive Decline.
|
Academic Article
|
Retinal Neurodegeneration in Euglycemic Hyperinsulinemia, Prediabetes, and Diabetes.
|